NIH director Jay Bhattacharya has offered a new explanation for why the federal government canceled $500 million in contracts ...

NIH Director Jay Bhattacharya offered an explanation for the cancellation of mRNA vaccine contracts that didn't align with ...

The U.S. Food and Drug Administration (FDA) is unlikely to renew the authorization granted to use Pfizer (NYSE:PFE) and BioNTech’s (BNTX) COVID-19 vaccine in young children this fall, The Guardian ...

After BioNTech’s acquisition of CureVac closes, BioNTech will pay GSK another $130 million and a 1% royalty on rest-of-world ...

Known as promoter-proximal pausing, this interruption in the transcription activity of RNA polymerase II—the enzyme ...

The government’s cancellation of almost $500 million in contracts involving mRNA vaccines could halt progress on cancer ...

The move drew sharp criticism from medical and health experts. “Scrapping the fastest platform we have is a reckless move ...

The U.S. Department of Health and Human Services announced on Tuesday that it will cancel $500 million worth of projects ...

President Trump’s laissez-faire approach is notable, given that the development of the Covid vaccine was seen as one of his ...

The fundraise will help advance a cancer therapy that’s already shown early promise in people whose cancers haven’t responded ...